Portugal

Pharmaceutical companies, NGOs, and patient organizations were among the 129 respondents to the European Commission’s consultation on its draft implementing act for joint clinical assessments – but opinions on the proposal were divided.

A round-up of the latest appointments in Europe's consumer health market: Cooper Consumer Health names Spain & Portugal head; Orkla Health adds to board; TheOTCLab appoints first Germany manager; Dr. Pfleger hires digital specialist.

Haleon has launched in Europe nasal spray technology under the Otrivin brand that is the result of a seven year partnership with Aptar Pharma. Otrivin Nasal Mist’s design is a “significant improvement on other pump devices,” Haleon claims.

Generis Farmaceutica, acquired by Aurobindo six years ago, says it is now the pharmaceutical “sector leader” in Portugal.

The proposed European Health Data Space aims to enable the seamless transition of health data sharing for certain purposes across the EU. A new report highlights how national variations in data storage and budgetary constraints may affect the initiative’s success.

Gingko biloba's cardiovascular benefits may be behind the popular ingredient's wide range of applications, from dementia to tinnitus, suggest researchers at the University of Lisbon, Portugal.

Amsterdam-based TheOTCLab has received an EU CE mark for its new wart and verruca OTC freezing device Dr. Yglo. The firm plans to launch the product in Europe in Italy, Portugal, Estonia, Latvia, and Lithuania, and will separately look to take it further afield to the US and South Africa.

The monkeypox cases reported this month are evidence of chains of transmission of the virus, according to the European Centre for Disease Prevention and Control, which says that vaccination of high-risk close contacts should be considered after a benefit-risk assessment.

Neuraxpharm has appointed Jörg Gärtner to lead its business in Switzerland, as the CNS specialist prepares to roll out its medical cannabis portfolio in the region.

Round-up of European consumer health news: Probiotics specialist BioGaia plots US expansion with acquisition of distribution partner; Spain's Rubió enters the dietary supplements space with Fisiopharma; and Portugal's Sidefarma receives investment from private-equity firm Atena.